Skip to main content
Premium Trial:

Request an Annual Quote

People In The News: Apr 20, 2012

NEW YORK (GenomeWeb News) – Fluidigm has tapped Dan Clutter as North American sales director for its eastern sales region. He will be responsible for sales growth in the eastern US and Canada and will be a member of Fluidigm's North American commercial leadership team, according to a spokesperson. Clutter joins Fluidigm from Gentel Biosciences, where he had served as vice president of commercial development since 2009. Before that, he was vice president of sales at NimbleGen Systems, now Roche NimbleGen.


CombiMatrix has named Ronald Wagner, a physician and specialist in reproductive genetics, to serve on its scientific advisory board. Wagner is vice chair for research in obstetrics and gynecology for Columbia University Medical Center and director of reproductive genetics. He also was principal investigator for a National Institute of Child Health and Human Development-sponsored multi-center study comparing chromosomal microarray testing to karyotyping.


Response Biomedical has hired Jeffrey Purvin to be its new CEO. Purvin was chairman and CEO of Calibra Medical for five years and he held the same positions at Metrika. Purvin also was a divisional president at Datascope, a VP and GM in GlaxoSmithKline's Consumer Healthcare division, and he worked in marketing at Bristol-Myers Squibb.


The Critical Path Institute has chosen Steven Broadbent as its new chief operating officer. Since early 2009, Broadbent has been the director of consortia operations at the institute. Before joining C-Path, Broadbent was an executive at IBM for nearly 31 years.

Broadbent will take over for Rick Myers, who recently stepped down from the post in order to focus on his role as chairman of the Arizona Board of Regents. Myers will remain a member of C-Path's board of directors.


Matthias Mann, director of the Max Planck Institute of Biochemistry, has been awarded the 2012 Louis-Jeantet Prize for Medicine and the 2012 Ernst Schering Prize for his work developing mass spectrometry procedures for protein analysis and methods for large-scale proteomics. Mann also serves as coordinator for the European Commission's PROSPECTS (proteomics specification in time and space) program.


Steve VanNurden, current chair of Mayo Clinic Ventures, has been named president and chief financial officer of the Fitzsimons Redevelopment Authority in Aurora, Colo., FRA said this week. In the new position, VanNurden will work with universities, local economic development agencies, state and local governments, and the bioscience industry to promote development of the 180 acre Colorado Science and Technology Park near the University of Colorado's Anschutz Medical Campus in Aurora. The FRA directs commercial development in the Fitzsimons Life Sciences District and at its partner, the Forest City Science and Technology Group.

VanNurdern previously held a variety of positions at the Mayo Clinic, and before that he worked at Cargill, US Bank, and Aerodrome Airline Services.


Biotech company Integragen has appointed Michael Dresner to be national sales director. In the role, he will be responsible for the company's US sales efforts for its autism risk assessment test. Dresner formerly was director of client and patient services for Oxford Immunotec and national accounts manager for anatomical pathology instruments at Thermo Fisher Scientific, and he held positions at Athena Diagnostics, GlaxoSmithKline, and Novartis Pharmaceuticals.


Diagenic said this week that CEO Erik Christensen has resigned from his position, and the company has named Henrik Lund, chairman of the board of directors, to step in as interim CEO. Lund has left his position on the board to Ingrid Wiik, who is deputy chairman of the board, until the annual general meeting in June. Christensen has been CEO since 2007.


Pathway Genomics has formed a scientific advisory board, which will include Arne Astrup, Claude Bouchard, and Ken Fujioka. Astrup is head of the department of human nutrition at the University of Copenhagen, Bouchard is executive director of the Pennington Biomedical Research Center, and Fujioka is director of the Scripps Nutrition and Metabolic Research Center.


Dotmatics has appointed Mariana Vaschetto to be VP of business development and marketing for Europe, the Middle East, Africa, and Latin America. Vaschetto has held senior scientific marketing and sales positions at Accelrys, Genelogics, and CambridgeSoft.


Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.